Cargando…

Hypofibrinolytic State in Subjects with Type 2 Diabetes Mellitus Aggravated by the Metabolic Syndrome before Clinical Manifestations of Atherothrombotic Disease

Background. Metabolic and genetic factors induce plasminogen activator inhibitor type-1 (PAI-1) overexpression; higher PAI-1 levels decrease fibrinolysis and promote atherothrombosis. Aim. To assess PAI-1 antigen levels among subjects with type 2 diabetes mellitus (T2DM) plus Metabolic Syndrome (Met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aburto-Mejía, Elsa, Santiago-Germán, David, Martínez-Marino, Manuel, María Eugenia Galván-Plata, Almeida-Gutiérrez, Eduardo, López-Alarcón, Mardia, Hernández-Juárez, Jesús, Alvarado-Moreno, Antonio, Leaños-Miranda, Alfredo, Majluf-Cruz, Abraham, Isordia-Salas, Irma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320378/ https://www.ncbi.nlm.nih.gov/pubmed/28271069 http://dx.doi.org/10.1155/2017/6519704

Ejemplares similares

Proinflammatory and Prothrombotic State in Subjects with Different Glucose Tolerance Status before Cardiovascular Disease
por: Isordia-Salas, Irma, et al.
Publicado: (2014)

Genetic Variants Associated with High Susceptibility of Premature Ischemic Stroke
por: Isordia-Salas, Irma, et al.
Publicado: (2023)

Genetic Polymorphisms Associated with Thrombotic Disease Comparison of Two Territories: Myocardial Infarction and Ischemic Stroke
por: Isordia-Salas, Irma, et al.
Publicado: (2019)

Polymorphisms in the Renin-Angiotensin System and eNOS Glu298Asp Genes Are Associated with Increased Risk for Essential Hypertension in a Mexican Population
por: Isordia-Salas, Irma, et al.
Publicado: (2023)

Prevalence of Metabolic Syndrome Components in an Urban Mexican Sample: Comparison between Two Classifications
por: Isordia-Salas, Irma, et al.
Publicado: (2012)

Morphological and functional alterations in endothelial colony-forming cells from recovered COVID-19 patients
por: Alvarado-Moreno, José Antonio, et al.
Publicado: (2021)

The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19
por: Ekholm, M., et al.
Publicado: (2021)

Urinary IgM excretion: a reliable marker for adverse pregnancy outcomes in women with chronic kidney disease
por: Leaños-Miranda, Alfredo, et al.
Publicado: (2018)

Role of oral anticoagulant therapy for secondary prevention in patients with stable atherothrombotic disease manifestations
por: Cho, Sung Won, et al.
Publicado: (2019)

Reduced proliferation of endothelial colony-forming cells in unprovoked venous thromboembolic disease as a consequence of endothelial dysfunction
por: Hernandez-Lopez, Rubicel, et al.
Publicado: (2017)

Antiplatelet combinations for prevention of atherothrombotic events
por: Bollati, Mario, et al.
Publicado: (2011)

Novel Antiplatelet Therapies for Atherothrombotic Diseases
por: Majithia, Arjun, et al.
Publicado: (2019)

Hematopoiesis of Indeterminate Potential and Atherothrombotic Risk
por: Murphy, Andrew J., et al.
Publicado: (2022)

Unexplored Roles of Erythrocytes in Atherothrombotic Stroke
por: Papadopoulos, Charalampos, et al.
Publicado: (2023)

PCSK9 as an Atherothrombotic Risk Factor
por: Sotler, Tadeja, et al.
Publicado: (2023)

Abo Blood Group, Atherothrombotic Comorbidities, and COVID-19: A Case-Control Study of their Association in the Mexican Population
por: Gamboa-Aguilar, Jacqueline, et al.
Publicado: (2022)

Environmental noise exposure is associated with atherothrombotic risk
por: Koczorowski, Magali, et al.
Publicado: (2022)

Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases
por: Petrucci, Giovanna, et al.
Publicado: (2022)

Circulating angiogenic factors are related to the severity of gestational hypertension and preeclampsia, and their adverse outcomes
por: Leaños-Miranda, Alfredo, et al.
Publicado: (2017)

The Role of Biomarkers in Atherothrombotic Stroke—A Systematic Review
por: Andone, Sebastian, et al.
Publicado: (2021)

Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk
por: Mauriello, Alfredo, et al.
Publicado: (2023)

Activation of the Carboxypeptidase U (CPU, TAFIa, CPB2) System in Patients with SARS-CoV-2 Infection Could Contribute to COVID-19 Hypofibrinolytic State and Disease Severity Prognosis
por: Claesen, Karen, et al.
Publicado: (2022)

Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: A prospective study
por: Hernandez-Juarez, Jesus, et al.
Publicado: (2014)

Microcirculation and atherothrombotic parameters in prolactinoma patients: a pilot study
por: Reuwer, Anne Q., et al.
Publicado: (2011)

Medicinal Herbals with Antiplatelet Properties Benefit in Coronary Atherothrombotic Diseases
por: Mohd Nor, Nurul Huda, et al.
Publicado: (2016)

Oxidative Stress in the Pathogenesis of Antiphospholipid Syndrome: Implications for the Atherothrombotic Process
por: Nocella, Cristina, et al.
Publicado: (2021)

Antiplatelet Therapy in Atherothrombotic Diseases: Similarities and Differences Across Guidelines
por: Jourdi, Georges, et al.
Publicado: (2022)

Cystathionine β-synthase and methylenetetrahydrofolate reductase mutations in Mexican individuals with hyperhomocysteinemia
por: Figueroa-Torres, Anahi Guadalupe, et al.
Publicado: (2020)

Lower circulating angiotensin II levels are related to the severity of preeclampsia and its risk as disclosed by a specific bioassay
por: Leaños-Miranda, Alfredo, et al.
Publicado: (2018)

MRAS Genetic Variation Is Associated with Atherothrombotic Stroke in the Han Chinese Population
por: Liu, Hua, et al.
Publicado: (2013)

Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease
por: Bergmark, Brian A., et al.
Publicado: (2018)

The PARTHENON Clinical Development Program: the Role of Ticagrelor in Patients with Atherothrombotic Disease
por: Dobesh, Paul P., et al.
Publicado: (2017)

Serum semaphorin 7A is associated with the risk of acute atherothrombotic stroke
por: You, Tao, et al.
Publicado: (2019)

Synthesis and Preliminary Evaluation of N-Oxide Derivatives for the Prevention of Atherothrombotic Events
por: Rosseto, Leandro Augusto, et al.
Publicado: (2015)

Going “Green” in the Prevention and Management of Atherothrombotic Diseases: The Role of Dietary Polyphenols
por: Reis, Ana, et al.
Publicado: (2021)

The High-Risk Plaque Initiative: Primary Prevention of Atherothrombotic Events in the Asymptomatic Population
por: Falk, Erling, et al.
Publicado: (2011)

Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options
por: Fintel, Dan J
Publicado: (2012)

Ways of Coping and Biomarkers of an Increased Atherothrombotic Cardiovascular Disease Risk in Elderly Individuals
por: von Känel, Roland, et al.
Publicado: (2012)

Interplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitus
por: Soma, Prashilla, et al.
Publicado: (2015)

Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in antiphospholipid syndrome
por: Pérez-Sánchez, Carlos, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7n18hhj7nlqmd2r0mk8ne2ksks